Viewing Study NCT04640935


Ignite Creation Date: 2025-12-24 @ 10:14 PM
Ignite Modification Date: 2025-12-31 @ 9:40 AM
Study NCT ID: NCT04640935
Status: COMPLETED
Last Update Posted: 2020-11-23
First Post: 2020-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Paclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.
Sponsor: Centre Hospitalier Annecy Genevois
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module